BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32905914)

  • 1. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study.
    Shi Y; Song R; Wang L; Qi Y; Zhang H; Zhu J; Zhang X; Tang X; Zhan Q; Zhao Y; Swaab DF; Bao AM; Zhang Z
    J Affect Disord; 2020 Dec; 277():620-630. PubMed ID: 32905914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Based Electroencephalographic Phenotypes of Schizophrenia and Major Depressive Disorder.
    Jang KI; Kim S; Kim SY; Lee C; Chae JH
    Front Psychiatry; 2021; 12():745458. PubMed ID: 34721112
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.
    Kim EY; Lee MY; Kim SH; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():65-71. PubMed ID: 28223106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder.
    Zhang G; Li L; Kong Y; Xu D; Bao Y; Zhang Z; Liao Z; Jiao J; Fan D; Long X; Dai J; Xie C; Meng Z; Zhang Z
    Genes Dis; 2024 Mar; 11(2):1009-1021. PubMed ID: 37692510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma biomarker panel for major depressive disorder by quantitative proteomics using ensemble learning algorithm: A preliminary study.
    Zhang L; Liu C; Li Y; Wu Y; Wei Y; Zeng D; He S; Huang J; Li H
    Psychiatry Res; 2023 May; 323():115185. PubMed ID: 37003170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
    Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
    J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
    Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
    Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls.
    Chiou YJ; Huang TL
    PLoS One; 2019; 14(2):e0212373. PubMed ID: 30794585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local functional connectivity alterations in schizophrenia, bipolar disorder, and major depressive disorder.
    Wei Y; Chang M; Womer FY; Zhou Q; Yin Z; Wei S; Zhou Y; Jiang X; Yao X; Duan J; Xu K; Zuo XN; Tang Y; Wang F
    J Affect Disord; 2018 Aug; 236():266-273. PubMed ID: 29751242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Regulatory Network of Dorsolateral Prefrontal Cortex: a Master Regulator Analysis of Major Psychiatric Disorders.
    Bristot G; De Bastiani MA; Pfaffenseller B; Kapczinski F; Kauer-Sant'Anna M
    Mol Neurobiol; 2020 Mar; 57(3):1305-1316. PubMed ID: 31728928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
    Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
    Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Biomarkers in Major Depressive Disorder: An Update.
    Woods AG; Wormwood KL; Iosifescu DV; Murrough J; Darie CC
    Adv Exp Med Biol; 2019; 1140():585-600. PubMed ID: 31347073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
    Salvetat N; Checa-Robles FJ; Delacrétaz A; Cayzac C; Dubuc B; Vetter D; Dainat J; Lang JP; Gamma F; Weissmann D
    J Affect Disord; 2024 Jul; 356():385-393. PubMed ID: 38615844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.